Jianhua Zhou Selected Research

Carcinoma (Carcinomatosis)

1/2021	EBV as a high infection risk factor promotes RASSF10 methylation and induces cell proliferation in EBV-associated gastric cancer.
1/2020	Myocyte-specific enhancer factor 2D promotes tumorigenesis and progression in tongue squamous cell carcinoma.
1/2018	Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
1/2016	Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
6/2014	Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia.
12/2002	[Pathologic diagnosis and histogenesis of primary signet ring cell carcinoma of the prostate].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianhua Zhou Research Topics

Disease

60	Neoplasms (Cancer) 01/2022 - 12/2007
16	Neoplasm Metastasis (Metastasis) 11/2021 - 11/2009
12	Breast Neoplasms (Breast Cancer) 11/2021 - 11/2011
8	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2009
8	Infections 03/2018 - 06/2008
7	Inflammation (Inflammations) 01/2022 - 04/2017
6	Carcinogenesis 01/2022 - 06/2012
6	Carcinoma (Carcinomatosis) 01/2021 - 12/2002
6	Lymphatic Metastasis 07/2020 - 11/2009
5	Wounds and Injuries (Trauma) 01/2022 - 01/2017
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2010
5	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 01/2016
5	Lung Neoplasms (Lung Cancer) 03/2020 - 08/2009
5	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 08/2015 - 01/2002
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2016
3	COVID-19 03/2022 - 01/2020
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 06/2012
3	Nasopharyngeal Carcinoma 01/2019 - 04/2002
3	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 01/2009
3	Squamous Cell Carcinoma of Head and Neck 01/2016 - 11/2014
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2012
2	Fever (Fevers) 01/2022 - 01/2014
2	Hyperplasia 12/2021 - 01/2018
2	Thrombosis (Thrombus) 12/2021 - 06/2020
2	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 08/2014
2	Hyperlipidemias (Hyperlipidemia) 06/2021 - 01/2018
2	Bone Resorption 06/2021 - 11/2020
2	Thyroid Nodule (Nodule, Thyroid) 04/2021 - 01/2021
2	Hemolysis 01/2021 - 01/2019
2	Adenocarcinoma of Lung 01/2021 - 01/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 07/2007
2	Glioma (Gliomas) 10/2019 - 01/2017
2	Non-alcoholic Fatty Liver Disease 04/2019 - 12/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2018
2	Lymphoma (Lymphomas) 01/2019 - 01/2012
2	Fibrosis (Cirrhosis) 12/2018 - 10/2008
2	Chordoma 11/2017 - 10/2015
2	Astrocytoma (Pilocytic Astrocytoma) 01/2017 - 01/2017
2	Hypertension (High Blood Pressure) 04/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2012
17	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2002
9	Messenger RNA (mRNA)IBA 11/2021 - 07/2004
9	Biological ProductsIBA 11/2020 - 12/2008
6	Pharmaceutical PreparationsIBA 03/2020 - 11/2015
6	VaccinesIBA 03/2018 - 04/2002
5	EnzymesIBA 11/2021 - 12/2014
5	CateninsIBA 01/2018 - 08/2014
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 12/2012
4	RNA (Ribonucleic Acid)IBA 11/2021 - 03/2012
4	ParaffinIBA 01/2019 - 06/2012
3	LipidsIBA 06/2022 - 12/2018
3	CytokinesIBA 01/2022 - 01/2009
3	Circular RNAIBA 01/2021 - 04/2019
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 08/2016
3	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2018
3	LuciferasesIBA 01/2020 - 07/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2019 - 01/2016
3	Contrast MediaIBA 01/2019 - 05/2018
3	Peptide Initiation Factors (Initiation Factor)IBA 01/2019 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 05/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2017
2	GelatinIBA 01/2022 - 01/2017
2	HydrogelsIBA 12/2021 - 06/2019
2	Simvastatin (Zocor)FDA LinkGeneric 06/2021 - 01/2018
2	Capsules (Microcapsules)IBA 02/2021 - 01/2019
2	Competitive Endogenous RNAIBA 01/2021 - 01/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 01/2014
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	AndrogensIBA 01/2020 - 01/2018
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 06/2002
2	ChromatinIBA 01/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 11/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2019 - 01/2017
2	AlbuminsIBA 01/2019 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 08/2009
2	Bevacizumab (Avastin)FDA Link 11/2017 - 01/2016
2	AcidsIBA 11/2017 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2017
2	Eukaryotic Initiation Factor-4EIBA 01/2017 - 01/2017
2	Cyclin D1IBA 01/2017 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 05/2009
2	RNA Precursors (Precursor, mRNA)IBA 08/2015 - 01/2014
2	AntibodiesIBA 12/2014 - 12/2012
2	Formaldehyde (Formol)FDA Link 08/2014 - 05/2010
2	Neutralizing AntibodiesIBA 12/2012 - 08/2011
2	CaspasesIBA 06/2012 - 11/2011
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2012 - 05/2009
2	SurvivinIBA 06/2012 - 04/2008

Therapy/Procedure

17	Therapeutics 01/2021 - 12/2007
7	Drug Therapy (Chemotherapy) 08/2019 - 08/2009
3	Castration 01/2020 - 08/2016
3	Immunotherapy 01/2020 - 01/2009
3	Esophagectomy 01/2018 - 01/2009
2	Ablation Techniques 04/2021 - 01/2021
2	Radiofrequency Ablation 04/2021 - 01/2021
2	Aftercare (After-Treatment) 01/2019 - 10/2011
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 06/2011
2	Radiotherapy 10/2015 - 12/2002